BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2642474)

  • 1. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29.
    Nakagawa SH; Tager HS
    J Biol Chem; 1989 Jan; 264(1):272-9. PubMed ID: 2642474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linked [DAlaA1]Insulins. Evidence for a change in the conformation of the insulin monomer at its receptor.
    Saunders D; Freude K
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):655-9. PubMed ID: 7049891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence concerning insulin activity from the structure of a cross-linked derivative.
    Cutfield J; Cutfield S; Dodson E; Dodson G; Hodgkin D; Reynolds C
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):755-61. PubMed ID: 7024090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain.
    Nakagawa SH; Tager HS
    J Biol Chem; 1987 Sep; 262(25):12054-8. PubMed ID: 3305501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes.
    Pilch PF; Czech MP
    J Biol Chem; 1980 Feb; 255(4):1722-31. PubMed ID: 6986378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BpaB25 insulins. Photoactivatable analogues that quantitatively cross-link, radiolabel, and activate the insulin receptor.
    Shoelson SE; Lee J; Lynch CS; Backer JM; Pilch PF
    J Biol Chem; 1993 Feb; 268(6):4085-91. PubMed ID: 8382690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and properties of covalently linked insulin dimers.
    Schüttler A; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1982 Mar; 363(3):317-30. PubMed ID: 7042509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH; Tager HS
    J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological potency of covalent insulin-receptor complexes. Dependence on site of cross-linkage.
    Klotz G; Saunders DJ; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1984 Apr; 365(4):493-8. PubMed ID: 6376321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of insulin to bovine liver plasma membrane. Use of insulin analogues modified at the A1 residue.
    Rösen P; Simon M; Reinauer H
    Biochem J; 1980 Mar; 186(3):945-52. PubMed ID: 6994716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence concerning the mechanism of insulin-receptor interaction and the structure of the insulin receptor from biological properties of covalently linked insulin dimers.
    Tatnell MA; Jones RH; Willey KP; Schüttler A; Brandenburg D
    Biochem J; 1983 Dec; 216(3):687-94. PubMed ID: 6365079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions.
    Mirmira RG; Nakagawa SH; Tager HS
    J Biol Chem; 1991 Jan; 266(3):1428-36. PubMed ID: 1988428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the cross-linking model for the interaction of insulin with its receptor.
    Hammond BJ; Tikerpae J; Smith GD
    Am J Physiol; 1997 Jun; 272(6 Pt 1):E1136-44. PubMed ID: 9227462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intramolecular modification of azisobutyrylinsulin and the use of the modified hormone for the synthesis of polymeric derivatives].
    Vlasov GP; Izvarina NL; Illarionova NG
    Biokhimiia; 1981 May; 46(5):942-50. PubMed ID: 7028141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications.
    Zhao M; Wan ZL; Whittaker L; Xu B; Phillips NB; Katsoyannis PG; Ismail-Beigi F; Whittaker J; Weiss MA
    J Biol Chem; 2009 Nov; 284(46):32178-87. PubMed ID: 19773552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation.
    Mirmira RG; Tager HS
    J Biol Chem; 1989 Apr; 264(11):6349-54. PubMed ID: 2649499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent linking of photoreactive insulin to adipocytes produces a prolonged signal.
    Brandenburg D; Diaconescu C; Saunders D; Thamm P
    Nature; 1980 Aug; 286(5775):821-2. PubMed ID: 6995859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the subunit structure of insulin receptor and its competence to bind insulin and undergo phosphorylation.
    Pang DT; Lewis SD; Sharma BR; Shafer JA
    Arch Biochem Biophys; 1984 Nov; 234(2):629-38. PubMed ID: 6388504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs.
    Markussen J; Havelund S; Kurtzhals P; Andersen AS; Halstrøm J; Hasselager E; Larsen UD; Ribel U; Schäffer L; Vad K; Jonassen I
    Diabetologia; 1996 Mar; 39(3):281-8. PubMed ID: 8721773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.